#Coronavirus Disease Research #References (by AMEDEO, February 1 '25)

 

Antiviral Res

1. WU Q, Wu H, Hu Y, Zheng X, et al
   Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients.
   Antiviral Res. 2025 Jan 24:106092. doi: 10.1016/j.antiviral.2025.106092.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

2. HANKINS RJ, Handke L, Fey PD, Cavalieri RJ, et al
   Prospective, crossover, comparative study of two methods of chlorhexidine bathing.
   Infect Control Hosp Epidemiol. 2025 Jan 30:1-6. doi: 10.1017/ice.2024.
   PubMed         Abstract available
   
   
3. PISCHEL L, Aguolu OG, Ahmed N, Campbell MM, et al
   Social mixing patterns of United States healthcare personnel at a quaternary health center: a prospective observational study.
   Infect Control Hosp Epidemiol. 2025 Jan 30:1-9. doi: 10.1017/ice.2024.
   PubMed         Abstract available
   
   

   
   J Infect

4. ZSIGMOND B, Trecchi N, Ladhani SN, Doerholt K, et al
   Early outpatient treatment of SARS-COV-2 infection in non-hospitalised high-risk paediatric patients in London, UK.
   J Infect. 2025;90:106425.
   PubMed        
   
   
5. BENNETT C, Chau G, Clayton E, Chu L, et al
   Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial.
   J Infect. 2025 Jan 26:106428. doi: 10.1016/j.jinf.2025.106428.
   PubMed         Abstract available
   
   

   
   J Med Virol

6. LI J, Yan H, Li J, Ling F, et al
   Low Neutralization of SARS-CoV-2 Omicron BA5248, XBB15 and JN1 by Homologous Booster and Breakthrough Infection.
   J Med Virol. 2025;97:e70189.
   PubMed         Abstract available
   
   
7. 
   Correction to "Serum-Derived Bovine Immunoglobulin Treatment in COVID-19 Is Associated With Faster Resolution of Symptoms: A Randomized Pilot Clinical Trial".
   J Med Virol. 2025;97:e70202.
   PubMed        
   
   

   
   J Virol

8. WANG Y, Xia B, Gao Z
   A comprehensive review of current insights into the virulence factors of SARS-CoV-2.
   J Virol. 2025 Jan 29:e0204924. doi: 10.1128/jvi.02049.
   PubMed         Abstract available
   
   
9. LIU C, Kong N, Liu H, Zhang Y, et al
   FSTL1 and TLR4 interact with PEDV structural proteins to promote virus adsorption to host cells.
   J Virol. 2025;99:e0183724.
   PubMed         Abstract available
   
   
10. LYTRAS S, Lamb KD, Ito J, Grove J, et al
    Pathogen genomic surveillance and the AI revolution.
    J Virol. 2025 Jan 29:e0160124. doi: 10.1128/jvi.01601.
    PubMed         Abstract available
    
    
11. DUGUAY BA, Tooley TH, Pringle ES, Rohde JR, et al
    A yeast-based reverse genetics system to generate HCoV-OC43 reporter viruses encoding an eighth subgenomic RNA.
    J Virol. 2025 Jan 30:e0167124. doi: 10.1128/jvi.01671.
    PubMed         Abstract available
    
    
12. SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al
    mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.
    J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
    PubMed         Abstract available
    
    

    
    JAMA

13. ANDERER S
    COVID-19 Tied to Long-Term Kidney Function Decline.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28058.
    PubMed        
    
    

    
    Lancet

14. MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
    Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
    Lancet. 2025;405:314-328.
    PubMed         Abstract available
    
    
15. KERR S, Robertson C, Sheikh A
    Undervaccination and severe COVID-19 outcomes - Authors' reply.
    Lancet. 2025;405:302.
    PubMed        
    
    
16. MORRIS JA
    Undervaccination and severe COVID-19 outcomes.
    Lancet. 2025;405:301-302.
    PubMed        
    
    
17. JOFFE AR
    Undervaccination and severe COVID-19 outcomes.
    Lancet. 2025;405:301.
    PubMed        
    
    
18. DUNCAN CJA
    Antibody testing to predict SARS-CoV-2 risk in immunocompromised people.
    Lancet. 2025;405:276-278.
    PubMed        
    
    

    
    Nature

19. RAHARINIRINA NA, Gubela N, Bornigen D, Smith MR, et al
    SARS-CoV-2 evolution on a dynamic immune landscape.
    Nature. 2025 Jan 29. doi: 10.1038/s41586-024-08477.
    PubMed         Abstract available
    
    
20. MORALES AE, Dong Y, Brown T, Baid K, et al
    Bat genomes illuminate adaptations to viral tolerance and disease resistance.
    Nature. 2025 Jan 29. doi: 10.1038/s41586-024-08471.
    PubMed         Abstract available